Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis

AbstractObjectiveTo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.DesignSystematic review and network meta-analysis.Data sourcesMedline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Org...

Full description

Saved in:
Bibliographic Details
Published in:BMJ (Online) Vol. 371; p. m3934
Main Authors: Cheng, Hung-Yuan, McGuinness, Luke A, Elbers, Roy G, MacArthur, Georgina J, Taylor, Abigail, McAleenan, Alexandra, Dawson, Sarah, López-López, José A, Higgins, Julian P T, Cowlishaw, Sean, Lingford-Hughes, Anne, Hickman, Matthew, Kessler, David
Format: Journal Article
Language:English
Published: England British Medical Journal Publishing Group 25.11.2020
BMJ Publishing Group LTD
BMJ Publishing Group Ltd
Subjects:
ISSN:1756-1833, 0959-8138, 1756-1833
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract AbstractObjectiveTo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.DesignSystematic review and network meta-analysis.Data sourcesMedline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Organization’s International Clinical Trials Registry Platform.Study selectionRandomised controlled trials comparing two or more interventions that could be used in primary care. The population was patients with alcohol dependency diagnosed by standardised clinical tools and who became detoxified within four weeks.Data extractionOutcomes of interest were continuous abstinence from alcohol (effectiveness) and all cause dropouts (as a proxy for acceptability) at least 12 weeks after start of intervention.Results64 trials (43 interventions) were included. The median probability of abstinence across placebo arms was 25%. Compared with placebo, the only intervention associated with increased probability of abstinence and moderate certainty evidence was acamprosate (odds ratio 1.86, 95% confidence interval 1.49 to 2.33, corresponding to an absolute probability of 38%). Of the 62 included trials that reported all cause dropouts, interventions associated with a reduced number of dropouts compared with placebo (probability 50%) and moderate certainty of evidence were acamprosate (0.73, 0.62 to 0.86; 42%), naltrexone (0.70, 0.50 to 0.98; 41%), and acamprosate-naltrexone (0.30, 0.13 to 0.67; 17%). Acamprosate was the only intervention associated with moderate confidence in the evidence of effectiveness and acceptability up to 12 months. It is uncertain whether other interventions can help maintain abstinence and reduce dropouts because of low confidence in the evidence.ConclusionsEvidence is lacking for benefit from interventions that could be implemented in primary care settings for alcohol abstinence, other than for acamprosate. More evidence from high quality randomised controlled trials is needed, as are strategies using combined interventions (combinations of drug interventions or drug and psychosocial interventions) to improve treatment of alcohol dependency in primary care.Systematic review registrationPROSPERO CRD42016049779.
AbstractList To determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care. Systematic review and network meta-analysis. Medline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Organization's International Clinical Trials Registry Platform. Randomised controlled trials comparing two or more interventions that could be used in primary care. The population was patients with alcohol dependency diagnosed by standardised clinical tools and who became detoxified within four weeks. Outcomes of interest were continuous abstinence from alcohol (effectiveness) and all cause dropouts (as a proxy for acceptability) at least 12 weeks after start of intervention. 64 trials (43 interventions) were included. The median probability of abstinence across placebo arms was 25%. Compared with placebo, the only intervention associated with increased probability of abstinence and moderate certainty evidence was acamprosate (odds ratio 1.86, 95% confidence interval 1.49 to 2.33, corresponding to an absolute probability of 38%). Of the 62 included trials that reported all cause dropouts, interventions associated with a reduced number of dropouts compared with placebo (probability 50%) and moderate certainty of evidence were acamprosate (0.73, 0.62 to 0.86; 42%), naltrexone (0.70, 0.50 to 0.98; 41%), and acamprosate-naltrexone (0.30, 0.13 to 0.67; 17%). Acamprosate was the only intervention associated with moderate confidence in the evidence of effectiveness and acceptability up to 12 months. It is uncertain whether other interventions can help maintain abstinence and reduce dropouts because of low confidence in the evidence. Evidence is lacking for benefit from interventions that could be implemented in primary care settings for alcohol abstinence, other than for acamprosate. More evidence from high quality randomised controlled trials is needed, as are strategies using combined interventions (combinations of drug interventions or drug and psychosocial interventions) to improve treatment of alcohol dependency in primary care. PROSPERO CRD42016049779.
ObjectiveTo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.DesignSystematic review and network meta-analysis.Data sourcesMedline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Organization’s International Clinical Trials Registry Platform.Study selectionRandomised controlled trials comparing two or more interventions that could be used in primary care. The population was patients with alcohol dependency diagnosed by standardised clinical tools and who became detoxified within four weeks.Data extractionOutcomes of interest were continuous abstinence from alcohol (effectiveness) and all cause dropouts (as a proxy for acceptability) at least 12 weeks after start of intervention.Results64 trials (43 interventions) were included. The median probability of abstinence across placebo arms was 25%. Compared with placebo, the only intervention associated with increased probability of abstinence and moderate certainty evidence was acamprosate (odds ratio 1.86, 95% confidence interval 1.49 to 2.33, corresponding to an absolute probability of 38%). Of the 62 included trials that reported all cause dropouts, interventions associated with a reduced number of dropouts compared with placebo (probability 50%) and moderate certainty of evidence were acamprosate (0.73, 0.62 to 0.86; 42%), naltrexone (0.70, 0.50 to 0.98; 41%), and acamprosate-naltrexone (0.30, 0.13 to 0.67; 17%). Acamprosate was the only intervention associated with moderate confidence in the evidence of effectiveness and acceptability up to 12 months. It is uncertain whether other interventions can help maintain abstinence and reduce dropouts because of low confidence in the evidence.ConclusionsEvidence is lacking for benefit from interventions that could be implemented in primary care settings for alcohol abstinence, other than for acamprosate. More evidence from high quality randomised controlled trials is needed, as are strategies using combined interventions (combinations of drug interventions or drug and psychosocial interventions) to improve treatment of alcohol dependency in primary care.Systematic review registrationPROSPERO CRD42016049779.
AbstractObjectiveTo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.DesignSystematic review and network meta-analysis.Data sourcesMedline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Organization’s International Clinical Trials Registry Platform.Study selectionRandomised controlled trials comparing two or more interventions that could be used in primary care. The population was patients with alcohol dependency diagnosed by standardised clinical tools and who became detoxified within four weeks.Data extractionOutcomes of interest were continuous abstinence from alcohol (effectiveness) and all cause dropouts (as a proxy for acceptability) at least 12 weeks after start of intervention.Results64 trials (43 interventions) were included. The median probability of abstinence across placebo arms was 25%. Compared with placebo, the only intervention associated with increased probability of abstinence and moderate certainty evidence was acamprosate (odds ratio 1.86, 95% confidence interval 1.49 to 2.33, corresponding to an absolute probability of 38%). Of the 62 included trials that reported all cause dropouts, interventions associated with a reduced number of dropouts compared with placebo (probability 50%) and moderate certainty of evidence were acamprosate (0.73, 0.62 to 0.86; 42%), naltrexone (0.70, 0.50 to 0.98; 41%), and acamprosate-naltrexone (0.30, 0.13 to 0.67; 17%). Acamprosate was the only intervention associated with moderate confidence in the evidence of effectiveness and acceptability up to 12 months. It is uncertain whether other interventions can help maintain abstinence and reduce dropouts because of low confidence in the evidence.ConclusionsEvidence is lacking for benefit from interventions that could be implemented in primary care settings for alcohol abstinence, other than for acamprosate. More evidence from high quality randomised controlled trials is needed, as are strategies using combined interventions (combinations of drug interventions or drug and psychosocial interventions) to improve treatment of alcohol dependency in primary care.Systematic review registrationPROSPERO CRD42016049779.
To determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.OBJECTIVETo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.Systematic review and network meta-analysis.DESIGNSystematic review and network meta-analysis.Medline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Organization's International Clinical Trials Registry Platform.DATA SOURCESMedline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Organization's International Clinical Trials Registry Platform.Randomised controlled trials comparing two or more interventions that could be used in primary care. The population was patients with alcohol dependency diagnosed by standardised clinical tools and who became detoxified within four weeks.STUDY SELECTIONRandomised controlled trials comparing two or more interventions that could be used in primary care. The population was patients with alcohol dependency diagnosed by standardised clinical tools and who became detoxified within four weeks.Outcomes of interest were continuous abstinence from alcohol (effectiveness) and all cause dropouts (as a proxy for acceptability) at least 12 weeks after start of intervention.DATA EXTRACTIONOutcomes of interest were continuous abstinence from alcohol (effectiveness) and all cause dropouts (as a proxy for acceptability) at least 12 weeks after start of intervention.64 trials (43 interventions) were included. The median probability of abstinence across placebo arms was 25%. Compared with placebo, the only intervention associated with increased probability of abstinence and moderate certainty evidence was acamprosate (odds ratio 1.86, 95% confidence interval 1.49 to 2.33, corresponding to an absolute probability of 38%). Of the 62 included trials that reported all cause dropouts, interventions associated with a reduced number of dropouts compared with placebo (probability 50%) and moderate certainty of evidence were acamprosate (0.73, 0.62 to 0.86; 42%), naltrexone (0.70, 0.50 to 0.98; 41%), and acamprosate-naltrexone (0.30, 0.13 to 0.67; 17%). Acamprosate was the only intervention associated with moderate confidence in the evidence of effectiveness and acceptability up to 12 months. It is uncertain whether other interventions can help maintain abstinence and reduce dropouts because of low confidence in the evidence.RESULTS64 trials (43 interventions) were included. The median probability of abstinence across placebo arms was 25%. Compared with placebo, the only intervention associated with increased probability of abstinence and moderate certainty evidence was acamprosate (odds ratio 1.86, 95% confidence interval 1.49 to 2.33, corresponding to an absolute probability of 38%). Of the 62 included trials that reported all cause dropouts, interventions associated with a reduced number of dropouts compared with placebo (probability 50%) and moderate certainty of evidence were acamprosate (0.73, 0.62 to 0.86; 42%), naltrexone (0.70, 0.50 to 0.98; 41%), and acamprosate-naltrexone (0.30, 0.13 to 0.67; 17%). Acamprosate was the only intervention associated with moderate confidence in the evidence of effectiveness and acceptability up to 12 months. It is uncertain whether other interventions can help maintain abstinence and reduce dropouts because of low confidence in the evidence.Evidence is lacking for benefit from interventions that could be implemented in primary care settings for alcohol abstinence, other than for acamprosate. More evidence from high quality randomised controlled trials is needed, as are strategies using combined interventions (combinations of drug interventions or drug and psychosocial interventions) to improve treatment of alcohol dependency in primary care.CONCLUSIONSEvidence is lacking for benefit from interventions that could be implemented in primary care settings for alcohol abstinence, other than for acamprosate. More evidence from high quality randomised controlled trials is needed, as are strategies using combined interventions (combinations of drug interventions or drug and psychosocial interventions) to improve treatment of alcohol dependency in primary care.PROSPERO CRD42016049779.SYSTEMATIC REVIEW REGISTRATIONPROSPERO CRD42016049779.
Author Lingford-Hughes, Anne
López-López, José A
Cowlishaw, Sean
Elbers, Roy G
Hickman, Matthew
McAleenan, Alexandra
Kessler, David
Cheng, Hung-Yuan
McGuinness, Luke A
Taylor, Abigail
Higgins, Julian P T
MacArthur, Georgina J
Dawson, Sarah
Author_xml – sequence: 1
  givenname: Hung-Yuan
  surname: Cheng
  fullname: Cheng, Hung-Yuan
  organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
– sequence: 2
  givenname: Luke A
  surname: McGuinness
  fullname: McGuinness, Luke A
  organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
– sequence: 3
  givenname: Roy G
  surname: Elbers
  fullname: Elbers, Roy G
  organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
– sequence: 4
  givenname: Georgina J
  surname: MacArthur
  fullname: MacArthur, Georgina J
  organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
– sequence: 5
  givenname: Abigail
  surname: Taylor
  fullname: Taylor, Abigail
  organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
– sequence: 6
  givenname: Alexandra
  surname: McAleenan
  fullname: McAleenan, Alexandra
  organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
– sequence: 7
  givenname: Sarah
  surname: Dawson
  fullname: Dawson, Sarah
  organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
– sequence: 8
  givenname: José A
  surname: López-López
  fullname: López-López, José A
  organization: Department of Basic Psychology and Methodology, University of Murcia, Spain
– sequence: 9
  givenname: Julian P T
  surname: Higgins
  fullname: Higgins, Julian P T
  organization: National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK
– sequence: 10
  givenname: Sean
  surname: Cowlishaw
  fullname: Cowlishaw, Sean
  organization: Department of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia
– sequence: 11
  givenname: Anne
  surname: Lingford-Hughes
  fullname: Lingford-Hughes, Anne
  organization: Faculty of Medicine, Department of Brain Sciences, Imperial College London, London, UK
– sequence: 12
  givenname: Matthew
  surname: Hickman
  fullname: Hickman, Matthew
  organization: National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK
– sequence: 13
  givenname: David
  orcidid: 0000-0001-5333-132X
  surname: Kessler
  fullname: Kessler, David
  email: david.kessler@bristol.ac.uk
  organization: National Institute for Health Research School for Primary Care Research, University of Bristol, Bristol, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33239318$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1rVDEYhYNUbK1d-AckoIIubpuPe5OMC0GKX1BwU9chN_PGZrxJapKZOv_ejDOOtYqLkPDmOYf3cB6ig5giIPSYklNKuTgbw-I08Bnv76EjKgfRUcX5wa33ITopZUEIYVyqmRgeoEPOWVNQdYS-X2YwNUCs2McKedVePsWCa8LBtFE72Iyl-gjRAnY5BWwmm67S1BT4Ovtg8hpbk-EVLutSIZjqLc6w8nCDTZzjCPUm5a84QDWdiWZaF18eofvOTAVOdvcx-vzu7eX5h-7i0_uP528uurEXrHaOslEOcj5aRpSQlClhqRVOWi6YA2WsE0Zax9VgnXWkd1QAs73slZFgHD9Gr7e-18sxwNy2fNlMere3TsbrP3-iv9Jf0kpLoSRhtBm82Bnk9G0Jpergi4VpMhHSsmjWi14QRfpZQ5_eQRdpmVvgLcUJE2xo1JPbG-1X-VVKA15uAZtTKRncHqFEbzrXrXP9s_PGnt1hra9mU2EL46d_Kp5tFZvR_4yf_8b2Mf7mfgAeC8pp
CitedBy_id crossref_primary_10_1080_10550887_2023_2257106
crossref_primary_10_3390_ijerph20156514
crossref_primary_10_1111_ajad_13431
crossref_primary_10_1177_02537176241245083
crossref_primary_10_1007_s11920_024_01567_4
crossref_primary_10_1093_alcalc_agac070
crossref_primary_10_1055_a_1513_9420
crossref_primary_10_7326_M23_1419
crossref_primary_10_1111_apt_17665
crossref_primary_10_1111_acps_13802
crossref_primary_10_1016_j_jpsychires_2023_06_042
crossref_primary_10_1177_17557380211053031
crossref_primary_10_1111_add_16391
crossref_primary_10_1136_bmj_m4129
crossref_primary_10_1111_acem_14911
crossref_primary_10_1155_2022_7062105
crossref_primary_10_3390_ijerph18136923
crossref_primary_10_4331_wjbc_v12_i5_87
crossref_primary_10_1093_alcalc_agac043
crossref_primary_10_1016_j_addbeh_2024_108242
crossref_primary_10_1002_jhm_70033
crossref_primary_10_1038_s41386_021_01097_0
crossref_primary_10_1111_bph_15795
crossref_primary_10_3389_fpubh_2023_1110435
crossref_primary_10_1007_s00115_022_01385_0
crossref_primary_10_34133_jemdr_0001
crossref_primary_10_1016_j_phrs_2022_106204
crossref_primary_10_1136_bmj_n5
crossref_primary_10_1007_s15202_023_5631_7
crossref_primary_10_1080_14728214_2024_2342951
crossref_primary_10_56083_RCV5N2_085
Cites_doi 10.1111/j.1530-0277.2007.00536.x
10.1186/1748-5908-8-49
10.1016/S0306-4603(99)00065-9
10.1046/j.1360-0443.2002.00019.x
10.1002/14651858.CD001867.pub2
10.1097/00019442-200506000-00008
10.1186/s13643-017-0462-2
10.1371/journal.pone.0099682
10.1093/alcalc/agq077
10.1001/archpsyc.1997.01830200024004
10.7326/M14-2385
10.1371/journal.pone.0087366
10.15288/jsa.1998.59.631
10.1016/j.clinthera.2005.06.015
10.1002/jrsm.1044
10.1002/sim.3767
10.1034/j.1600-0447.2002.02332.x
10.1177/0269881112444324
10.1016/j.phrs.2008.03.001
10.1002/lary.25688
10.1136/bmj.38636.593461.68
10.1371/journal.pone.0076654
10.1111/add.13974
10.1001/jamapsychiatry.2013.4642
10.1186/s12913-017-2031-8
10.1097/01.ALC.0000108656.81563.05
10.1111/j.1530-0277.2008.00742.x
10.14748/bmr.v30.6393
10.1136/bmj.l4898
10.1111/j.1600-0447.2001.00150.x
10.1136/bmj.39469.432118.AD
10.1001/jama.1986.03380110055026
10.1093/alcalc/agh136
10.1016/j.jsat.2014.11.009
10.1080/10550490701375558
10.1609/icwsm.v3i1.13937
10.1002/14651858.CD004332.pub2
10.1111/add.12875
10.1097/ADT.0b013e318196d4e5
10.1007/978-1-4612-2878-3_44
10.1136/bmj.331.7516.541
10.1093/alcalc/agz106
10.1093/alcalc/agq005
10.1371/journal.pmed.1003082
10.1093/alcalc/36.5.413
10.1016/S0140-6736(14)61838-9
10.7759/cureus.3107
10.1111/j.1360-0443.2006.01433.x
10.4088/JCP.v65n1017
10.1002/cl2.1080
ContentType Journal Article
Copyright Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.
Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.
2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ
Copyright_xml – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.
– notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.
– notice: 2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ
DBID 9YT
ACMMV
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88I
8AF
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AN0
ASE
AZQEC
BBNVY
BENPR
BHPHI
BTHHO
CCPQU
DWQXO
FPQ
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K6X
K9.
KB0
LK8
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1136/bmj.m3934
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Science Database (Alumni Edition)
STEM Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
British Nursing Index
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
BMJ Journals
ProQuest One
ProQuest Central Korea
British Nursing Index (BNI) (1985 to Present)
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
British Nursing Index
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Research Library
Science Database (ProQuest)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
Proquest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
British Nursing Index
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Research Library Prep


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1756-1833
ExternalDocumentID PMC7687021
33239318
10_1136_bmj_m3934
bmj
Genre Network Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Journal Article
GeographicLocations United Kingdom--UK
GeographicLocations_xml – name: United Kingdom--UK
GrantInformation_xml – fundername: Department of Health
  grantid: DRF-2018-11-ST2-048
– fundername: Medical Research Council
  grantid: MR/N00616X/1
GroupedDBID 23N
39C
4.4
40O
53G
5GY
7RV
7X7
88I
8AF
8F7
8FE
8FH
8FI
8FJ
8G5
9YT
AACGO
AANCE
AAWJN
ABBHK
ABIVO
ABJNI
ABPLY
ABTLG
ABUWG
ABVAJ
ABXSQ
ACGFS
ACGOD
ACMFJ
ACMMV
ACPRK
AEUPB
AEXZC
AFKRA
AGFXO
AHMBA
AHNKE
AHQMW
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BBNVY
BENPR
BHPHI
BPHCQ
BTHHO
C45
CCPQU
CS3
DCCCD
DWQXO
EBS
EJD
F5P
FYUFA
GNUQQ
GUQSH
H13
HAJ
HCIFZ
HMCUK
HZ~
IPSME
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
L7B
LK8
M2O
M2P
M7P
NAPCQ
NXWIF
O9-
OVD
PHGZT
PQQKQ
PROAC
R53
RHI
RMJ
RV8
SA0
TEORI
UKHRP
VVN
WOQ
YFH
YQY
AAYXX
AFFHD
AN0
CITATION
IAG
IBB
IMI
PHGZM
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
ASE
FPQ
K6X
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
PUEGO
Q9U
7X8
5PM
ID FETCH-LOGICAL-b462t-f12b757dbc208671286c1c6f7c362fe8acf6a7cf385cfcf04f16e2c4748a7eaf3
IEDL.DBID M2P
ISICitedReferencesCount 45
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000595061600017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1756-1833
0959-8138
IngestDate Tue Nov 04 01:54:39 EST 2025
Sat Sep 27 19:43:41 EDT 2025
Mon Sep 08 13:52:30 EDT 2025
Mon Jul 21 06:02:07 EDT 2025
Tue Nov 18 22:24:09 EST 2025
Sat Nov 29 04:10:43 EST 2025
Thu Apr 24 23:09:47 EDT 2025
Thu Apr 24 22:50:29 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b462t-f12b757dbc208671286c1c6f7c362fe8acf6a7cf385cfcf04f16e2c4748a7eaf3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0001-5333-132X
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7687021
PMID 33239318
PQID 2464302625
PQPubID 2043523
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7687021
proquest_miscellaneous_2464608049
proquest_journals_2464302625
pubmed_primary_33239318
crossref_primary_10_1136_bmj_m3934
crossref_citationtrail_10_1136_bmj_m3934
bmj_primary_10_1136_bmj_m3934
bmj_journals_10_1136_bmj_m3934
PublicationCentury 2000
PublicationDate 20201125
2020-11-25
PublicationDateYYYYMMDD 2020-11-25
PublicationDate_xml – month: 11
  year: 2020
  text: 20201125
  day: 25
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMJ (Online)
PublicationTitleAbbrev BMJ
PublicationTitleAlternate BMJ
PublicationYear 2020
Publisher British Medical Journal Publishing Group
BMJ Publishing Group LTD
BMJ Publishing Group Ltd
Publisher_xml – name: British Medical Journal Publishing Group
– name: BMJ Publishing Group LTD
– name: BMJ Publishing Group Ltd
References Williams, Aspinall, Bellis (ref2) 2014; 384
(ref12) 2005; 331
Ahmed, Kotapati, Khan (ref47) 2018; 10
Hutton, Salanti, Caldwell (ref11) 2015; 162
Fuller, Branchey, Brightwell (ref23) 1986; 256
Lejoyeux, Lehert (ref55) 2011; 46
Moraes, de Campos, Figlie, Ferraz, Laranjeira (ref43) 2010; 9
Donoghue, Elzerbi, Saunders, Whittington, Pilling, Drummond (ref48) 2015; 110
Jirapramukpitak, Pattanaseri, Chua, Takizawa (ref42) 2020; 55
Adamson, Heather, Morton, Raistrick (ref13) 2010; 45
Greenhalgh, Peacock (ref15) 2005; 331
Harrison, Graham, van den Hoek, Dogherty, Carley, Angus (ref53) 2013; 8
Wetzel, Szegedi, Scheurich (ref45) 2004; 65
Dawson, Goldstein, Grant (ref14) 2007; 31
Rösner, Hackl-Herrwerth, Leucht, Vecchi, Srisurapanont, Soyka (ref49) 2010
Palpacuer, Duprez, Huneau (ref46) 2018; 113
Salanti, Del Giovane, Chaimani, Caldwell, Higgins (ref21) 2014; 9
Dawson, Grant, Stinson, Chou (ref5) 2006; 101
Gustafson, McTavish, Chih (ref37) 2014; 71
(ref40) 1998; 59
Skinner, Lahmek, Pham, Aubin (ref51) 2014; 9
Mann, Lehert, Morgan (ref17) 2004; 28
Dias, Welton, Caldwell, Ades (ref27) 2010; 29
Burtscheidt, Wölwer, Schwarz (ref39) 2001; 103
Higgins, Jackson, Barrett, Lu, Ades, White (ref26) 2012; 3
Liu, Wang, Zhang, Bai, Zhang (ref28) 2016; 126
Cornelius, Salloum, Haskett (ref33) 2000; 25
Sekhon, Cartwright, Francis (ref52) 2017; 17
Sterne, Savović, Page (ref18) 2019; 366
Gillam (ref8) 2008; 336
Gual, Lehert (ref31) 2001; 36
Burtscheidt, Wölwer, Schwarz, Strauss, Gaebel (ref38) 2002; 106
Ponce, Sánchez-García, Rubio, Rodríguez-Jiménez, Jiménez-Arriero, Palomo (ref36) 2005; 33
Nikolakopoulou, Higgins, Papakonstantinou (ref19) 2020; 17
Cornelius, Salloum, Ehler (ref32) 1997; 54
Stella, Addolorato, Rinaldi (ref24) 2008; 57
Lingford-Hughes, Welch, Peters, Nutt (ref58) 2012; 26
Friedmann, Rose, Swift, Stout, Millman, Stein (ref34) 2008; 32
Cheng, Elbers, Higgins (ref10) 2017; 6
Mann, Lehert, Morgan (ref57) 2004; 28
Oslin (ref35) 2005; 13
Chaimani, Higgins, Mavridis, Spyridonos, Salanti (ref22) 2013; 8
Boothby, Doering (ref56) 2005; 27
Coriale, De Rosa, Battagliese (ref41) 2019; 30
Timko, Below, Schultz, Brief, Cucciare (ref59) 2015; 52
Martinotti, Romanelli, Di Nicola, Reina, Mazza, Janiri (ref30) 2007; 16
Miller, Wilbourne (ref9) 2002; 97
Rösner, Hackl-Herrwerth, Leucht, Lehert, Vecchi, Soyka (ref50) 2010
Pelc, Hanak, Baert (ref44) 2005; 40
Papakonstantinou, Nikolakopoulou, Higgins (ref20) 2020; 16
Sekhon, Cartwright, Francis 2017; 17
Burtscheidt, Wölwer, Schwarz, Strauss, Gaebel 2002; 106
Pelc, Hanak, Baert 2005; 40
Timko, Below, Schultz, Brief, Cucciare 2015; 52
Fuller, Branchey, Brightwell 1986; 256
2005; 331
Dawson, Goldstein, Grant 2007; 31
Gustafson, McTavish, Chih 2014; 71
Adamson, Heather, Morton, Raistrick 2010; 45
Lingford-Hughes, Welch, Peters, Nutt 2012; 26
Oslin 2005; 13
1998; 59
Chaimani, Higgins, Mavridis, Spyridonos, Salanti 2013; 8
Salanti, Del Giovane, Chaimani, Caldwell, Higgins 2014; 9
Nikolakopoulou, Higgins, Papakonstantinou 2020; 17
Cornelius, Salloum, Haskett 2000; 25
Liu, Wang, Zhang, Bai, Zhang 2016; 126
Gillam 2008; 336
Friedmann, Rose, Swift, Stout, Millman, Stein 2008; 32
Harrison, Graham, van den Hoek, Dogherty, Carley, Angus 2013; 8
Rösner, Hackl-Herrwerth, Leucht, Lehert, Vecchi, Soyka 2010
Ahmed, Kotapati, Khan 2018; 10
Rösner, Hackl-Herrwerth, Leucht, Vecchi, Srisurapanont, Soyka 2010
Dawson, Grant, Stinson, Chou 2006; 101
Miller, Wilbourne 2002; 97
Dias, Welton, Caldwell, Ades 2010; 29
Williams, Aspinall, Bellis 2014; 384
Palpacuer, Duprez, Huneau 2018; 113
Papakonstantinou, Nikolakopoulou, Higgins 2020; 16
Higgins, Jackson, Barrett, Lu, Ades, White 2012; 3
Ponce, Sánchez-García, Rubio, Rodríguez-Jiménez, Jiménez-Arriero, Palomo 2005; 33
Gual, Lehert 2001; 36
Mann, Lehert, Morgan 2004; 28
Lejoyeux, Lehert 2011; 46
Cornelius, Salloum, Ehler 1997; 54
Jirapramukpitak, Pattanaseri, Chua, Takizawa 2020; 55
Greenhalgh, Peacock 2005; 331
Hutton, Salanti, Caldwell 2015; 162
Sterne, Savović, Page 2019; 366
Cheng, Elbers, Higgins 2017; 6
Stella, Addolorato, Rinaldi 2008; 57
Burtscheidt, Wölwer, Schwarz 2001; 103
Wetzel, Szegedi, Scheurich 2004; 65
Moraes, de Campos, Figlie, Ferraz, Laranjeira 2010; 9
Coriale, De Rosa, Battagliese 2019; 30
Boothby, Doering 2005; 27
Donoghue, Elzerbi, Saunders, Whittington, Pilling, Drummond 2015; 110
Martinotti, Romanelli, Di Nicola, Reina, Mazza, Janiri 2007; 16
Skinner, Lahmek, Pham, Aubin 2014; 9
2020112509201012000_371.nov25_2.m3934.37
2020112509201012000_371.nov25_2.m3934.34
2020112509201012000_371.nov25_2.m3934.35
2020112509201012000_371.nov25_2.m3934.32
2020112509201012000_371.nov25_2.m3934.33
2020112509201012000_371.nov25_2.m3934.30
2020112509201012000_371.nov25_2.m3934.31
2020112509201012000_371.nov25_2.m3934.38
2020112509201012000_371.nov25_2.m3934.39
2020112509201012000_371.nov25_2.m3934.25
2020112509201012000_371.nov25_2.m3934.26
2020112509201012000_371.nov25_2.m3934.23
2020112509201012000_371.nov25_2.m3934.24
2020112509201012000_371.nov25_2.m3934.21
2020112509201012000_371.nov25_2.m3934.22
2020112509201012000_371.nov25_2.m3934.20
2020112509201012000_371.nov25_2.m3934.1
2020112509201012000_371.nov25_2.m3934.2
2020112509201012000_371.nov25_2.m3934.29
2020112509201012000_371.nov25_2.m3934.27
2020112509201012000_371.nov25_2.m3934.28
2020112509201012000_371.nov25_2.m3934.14
2020112509201012000_371.nov25_2.m3934.58
2020112509201012000_371.nov25_2.m3934.15
2020112509201012000_371.nov25_2.m3934.59
2020112509201012000_371.nov25_2.m3934.12
2020112509201012000_371.nov25_2.m3934.56
2020112509201012000_371.nov25_2.m3934.13
2020112509201012000_371.nov25_2.m3934.57
2020112509201012000_371.nov25_2.m3934.10
2020112509201012000_371.nov25_2.m3934.54
2020112509201012000_371.nov25_2.m3934.11
2020112509201012000_371.nov25_2.m3934.55
2020112509201012000_371.nov25_2.m3934.52
2020112509201012000_371.nov25_2.m3934.53
2020112509201012000_371.nov25_2.m3934.18
2020112509201012000_371.nov25_2.m3934.19
2020112509201012000_371.nov25_2.m3934.16
2020112509201012000_371.nov25_2.m3934.17
2020112509201012000_371.nov25_2.m3934.7
2020112509201012000_371.nov25_2.m3934.8
2020112509201012000_371.nov25_2.m3934.9
2020112509201012000_371.nov25_2.m3934.3
2020112509201012000_371.nov25_2.m3934.4
2020112509201012000_371.nov25_2.m3934.5
2020112509201012000_371.nov25_2.m3934.6
2020112509201012000_371.nov25_2.m3934.50
2020112509201012000_371.nov25_2.m3934.51
2020112509201012000_371.nov25_2.m3934.47
2020112509201012000_371.nov25_2.m3934.48
2020112509201012000_371.nov25_2.m3934.45
2020112509201012000_371.nov25_2.m3934.46
2020112509201012000_371.nov25_2.m3934.43
2020112509201012000_371.nov25_2.m3934.44
2020112509201012000_371.nov25_2.m3934.41
2020112509201012000_371.nov25_2.m3934.42
2020112509201012000_371.nov25_2.m3934.49
Ponce (2020112509201012000_371.nov25_2.m3934.36) 2005; 33
2020112509201012000_371.nov25_2.m3934.40
33481761 - BMJ. 2020 Nov 25;371:m4129. doi: 10.1136/bmj.m4129.
33939485 - Ann Intern Med. 2021 May;174(5):JC51. doi: 10.7326/ACPJ202105180-051.
33402357 - BMJ. 2021 Jan 5;372:n5. doi: 10.1136/bmj.n5.
References_xml – volume: 106
  start-page: 227
  year: 2002
  ident: ref38
  article-title: Out-patient behaviour therapy in alcoholism: treatment outcome after 2 years
  publication-title: Acta Psychiatr Scand
– volume: 6
  start-page: 77
  year: 2017
  ident: ref10
  article-title: Therapeutic interventions for alcohol dependence in non-inpatient settings: a systematic review and network meta-analysis (protocol)
  publication-title: Syst Rev
– volume: 26
  start-page: 899
  year: 2012
  ident: ref58
  article-title: BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP
  publication-title: J Psychopharmacol
– volume: 17
  start-page: 88
  year: 2017
  ident: ref52
  article-title: Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework
  publication-title: BMC Health Serv Res
– volume: 366
  start-page: l4898
  year: 2019
  ident: ref18
  article-title: RoB 2: a revised tool for assessing risk of bias in randomised trials
  publication-title: BMJ
– volume: 162
  start-page: 777
  year: 2015
  ident: ref11
  article-title: The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
  publication-title: Ann Intern Med
– volume: 8
  start-page: 49
  year: 2013
  ident: ref53
  article-title: Guideline adaptation and implementation planning: a prospective observational study
  publication-title: Implement Sci
– volume: 46
  start-page: 61
  year: 2011
  ident: ref55
  article-title: Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies
  publication-title: Alcohol Alcohol
– volume: 27
  start-page: 695
  year: 2005
  ident: ref56
  article-title: Acamprosate for the treatment of alcohol dependence
  publication-title: Clin Ther
– volume: 45
  start-page: 136
  year: 2010
  ident: ref13
  article-title: Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes
  publication-title: Alcohol Alcohol
– volume: 126
  start-page: 951
  year: 2016
  ident: ref28
  article-title: Epley and Semont maneuvers for posterior canal benign paroxysmal positional vertigo: A network meta-analysis
  publication-title: Laryngoscope
– issue: 12
  year: 2010
  ident: ref49
  article-title: Opioid antagonists for alcohol dependence
  publication-title: Cochrane Database Syst Rev
– volume: 71
  start-page: 566
  year: 2014
  ident: ref37
  article-title: A smartphone application to support recovery from alcoholism: a randomized clinical trial
  publication-title: JAMA Psychiatry
– volume: 33
  start-page: 13
  year: 2005
  ident: ref36
  article-title: Eficacia de la naltrexona en el tratamiento de mujeres con trastorno por dependencia del alcohol
  publication-title: Actas Esp Psiquiatr
– volume: 256
  start-page: 1449
  year: 1986
  ident: ref23
  article-title: Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
  publication-title: JAMA
– volume: 28
  start-page: 51
  year: 2004
  ident: ref17
  article-title: The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis
  publication-title: Alcohol Clin Exp Res
– volume: 54
  start-page: 700
  year: 1997
  ident: ref32
  article-title: Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial
  publication-title: Arch Gen Psychiatry
– volume: 384
  start-page: 1953
  year: 2014
  ident: ref2
  article-title: Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
  publication-title: Lancet
– volume: 59
  start-page: 631
  year: 1998
  ident: ref40
  article-title: Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment
  publication-title: J Stud Alcohol
– volume: 36
  start-page: 413
  year: 2001
  ident: ref31
  article-title: Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain
  publication-title: Alcohol Alcohol
– volume: 40
  start-page: 302
  year: 2005
  ident: ref44
  article-title: Effect of community nurse follow-up when treating alcohol dependence with acamprosate
  publication-title: Alcohol Alcohol
– volume: 101
  start-page: 824
  year: 2006
  ident: ref5
  article-title: Estimating the effect of help-seeking on achieving recovery from alcohol dependence
  publication-title: Addiction
– volume: 97
  start-page: 265
  year: 2002
  ident: ref9
  article-title: Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders
  publication-title: Addiction
– volume: 31
  start-page: 2036
  year: 2007
  ident: ref14
  article-title: Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up
  publication-title: Alcohol Clin Exp Res
– volume: 13
  start-page: 491
  year: 2005
  ident: ref35
  article-title: Treatment of late-life depression complicated by alcohol dependence
  publication-title: Am J Geriatr Psychiatry
– issue: 9
  year: 2010
  ident: ref50
  article-title: Acamprosate for alcohol dependence
  publication-title: Cochrane Database Syst Rev
– volume: 9
  year: 2014
  ident: ref51
  article-title: Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis
  publication-title: PLoS One
– volume: 29
  start-page: 932
  year: 2010
  ident: ref27
  article-title: Checking consistency in mixed treatment comparison meta-analysis
  publication-title: Stat Med
– volume: 9
  year: 2014
  ident: ref21
  article-title: Evaluating the quality of evidence from a network meta-analysis
  publication-title: PLoS One
– volume: 32
  start-page: 1652
  year: 2008
  ident: ref34
  article-title: Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial
  publication-title: Alcohol Clin Exp Res
– volume: 336
  start-page: 536
  year: 2008
  ident: ref8
  article-title: Is the declaration of Alma Ata still relevant to primary health care?
  publication-title: BMJ
– volume: 17
  year: 2020
  ident: ref19
  article-title: CINeMA: An approach for assessing confidence in the results of a network meta-analysis
  publication-title: PLoS Med
– volume: 331
  start-page: 1064
  year: 2005
  ident: ref15
  article-title: Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources
  publication-title: BMJ
– volume: 3
  start-page: 98
  year: 2012
  ident: ref26
  article-title: Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
  publication-title: Res Synth Methods
– volume: 65
  start-page: 1406
  year: 2004
  ident: ref45
  article-title: Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study
  publication-title: J Clin Psychiatry
– volume: 10
  year: 2018
  ident: ref47
  article-title: Adding Psychotherapy to the Naltrexone Treatment of Alcohol Use Disorder: Meta-analytic Review
  publication-title: Cureus
– volume: 28
  start-page: 51
  year: 2004
  ident: ref57
  article-title: The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis
  publication-title: Alcohol Clin Exp Res
– volume: 55
  start-page: 171
  year: 2020
  ident: ref42
  article-title: Home-Based Contingency Management Delivered by Community Health Workers to Improve Alcohol Abstinence: A Randomized Control Trial
  publication-title: Alcohol Alcohol
– volume: 57
  start-page: 312
  year: 2008
  ident: ref24
  article-title: An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients
  publication-title: Pharmacol Res
– volume: 16
  year: 2020
  ident: ref20
  article-title: CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis
  publication-title: Campbell Syst Rev
– volume: 25
  start-page: 307
  year: 2000
  ident: ref33
  article-title: Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study
  publication-title: Addict Behav
– volume: 103
  start-page: 24
  year: 2001
  ident: ref39
  article-title: Out-patient behaviour therapy in alcoholism: relapse rates after 6 months
  publication-title: Acta Psychiatr Scand
– volume: 16
  start-page: 247
  year: 2007
  ident: ref30
  article-title: Oxcarbazepine at high dosages for the treatment of alcohol dependence
  publication-title: Am J Addict
– volume: 331
  start-page: 541
  year: 2005
  ident: ref12
  article-title: Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT)
  publication-title: BMJ
– volume: 113
  start-page: 220
  year: 2018
  ident: ref46
  article-title: Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate
  publication-title: Addiction
– volume: 110
  start-page: 920
  year: 2015
  ident: ref48
  article-title: The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis
  publication-title: Addiction
– volume: 9
  start-page: 18
  year: 2010
  ident: ref43
  article-title: Home visits in the outpatient treatment of individuals dependent on alcohol: Randomized clinical trial
  publication-title: Addict Disord Their Treat
– volume: 52
  start-page: 31
  year: 2015
  ident: ref59
  article-title: Patient and program factors that bridge the detoxification-treatment gap: a structured evidence review
  publication-title: J Subst Abuse Treat
– volume: 8
  year: 2013
  ident: ref22
  article-title: Graphical tools for network meta-analysis in STATA
  publication-title: PLoS One
– volume: 30
  start-page: 125
  year: 2019
  ident: ref41
  article-title: Motivational enhancement therapy versus cognitive behavioral therapy in a cohort of men and women with alcohol use disorder
  publication-title: Biomedical Reviews
– volume: 17
  year: 2020
  article-title: CINeMA: An approach for assessing confidence in the results of a network meta-analysis
  publication-title: PLoS Med
– volume: 97
  start-page: 265
  year: 2002
  article-title: Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders
  publication-title: Addiction
– volume: 162
  start-page: 777
  year: 2015
  article-title: The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
  publication-title: Ann Intern Med
– volume: 46
  start-page: 61
  year: 2011
  article-title: Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies
  publication-title: Alcohol Alcohol
– volume: 31
  start-page: 2036
  year: 2007
  article-title: Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up
  publication-title: Alcohol Clin Exp Res
– volume: 59
  start-page: 631
  year: 1998
  article-title: Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment
  publication-title: J Stud Alcohol
– volume: 29
  start-page: 932
  year: 2010
  article-title: Checking consistency in mixed treatment comparison meta-analysis
  publication-title: Stat Med
– volume: 26
  start-page: 899
  year: 2012
  article-title: BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP
  publication-title: J Psychopharmacol
– volume: 27
  start-page: 695
  year: 2005
  article-title: Acamprosate for the treatment of alcohol dependence
  publication-title: Clin Ther
– volume: 40
  start-page: 302
  year: 2005
  article-title: Effect of community nurse follow-up when treating alcohol dependence with acamprosate
  publication-title: Alcohol Alcohol
– volume: 16
  year: 2020
  article-title: CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis
  publication-title: Campbell Syst Rev
– volume: 30
  start-page: 125
  year: 2019
  article-title: Motivational enhancement therapy versus cognitive behavioral therapy in a cohort of men and women with alcohol use disorder
  publication-title: Biomedical Reviews
– volume: 331
  start-page: 541
  year: 2005
  article-title: Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT)
  publication-title: BMJ
– volume: 3
  start-page: 98
  year: 2012
  article-title: Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
  publication-title: Res Synth Methods
– volume: 71
  start-page: 566
  year: 2014
  article-title: A smartphone application to support recovery from alcoholism: a randomized clinical trial
  publication-title: JAMA Psychiatry
– volume: 256
  start-page: 1449
  year: 1986
  article-title: Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
  publication-title: JAMA
– volume: 25
  start-page: 307
  year: 2000
  article-title: Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study
  publication-title: Addict Behav
– volume: 366
  start-page: l4898
  year: 2019
  article-title: RoB 2: a revised tool for assessing risk of bias in randomised trials
  publication-title: BMJ
– volume: 110
  start-page: 920
  year: 2015
  article-title: The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis
  publication-title: Addiction
– volume: 9
  year: 2014
  article-title: Evaluating the quality of evidence from a network meta-analysis
  publication-title: PLoS One
– volume: 33
  start-page: 13
  year: 2005
  article-title: Eficacia de la naltrexona en el tratamiento de mujeres con trastorno por dependencia del alcohol
  publication-title: Actas Esp Psiquiatr
– volume: 106
  start-page: 227
  year: 2002
  article-title: Out-patient behaviour therapy in alcoholism: treatment outcome after 2 years
  publication-title: Acta Psychiatr Scand
– volume: 9
  year: 2014
  article-title: Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis
  publication-title: PLoS One
– volume: 103
  start-page: 24
  year: 2001
  article-title: Out-patient behaviour therapy in alcoholism: relapse rates after 6 months
  publication-title: Acta Psychiatr Scand
– volume: 52
  start-page: 31
  year: 2015
  article-title: Patient and program factors that bridge the detoxification-treatment gap: a structured evidence review
  publication-title: J Subst Abuse Treat
– issue: 12
  year: 2010
  article-title: Opioid antagonists for alcohol dependence
  publication-title: Cochrane Database Syst Rev
– volume: 55
  start-page: 171
  year: 2020
  article-title: Home-Based Contingency Management Delivered by Community Health Workers to Improve Alcohol Abstinence: A Randomized Control Trial
  publication-title: Alcohol Alcohol
– volume: 6
  start-page: 77
  year: 2017
  article-title: Therapeutic interventions for alcohol dependence in non-inpatient settings: a systematic review and network meta-analysis (protocol)
  publication-title: Syst Rev
– volume: 8
  year: 2013
  article-title: Graphical tools for network meta-analysis in STATA
  publication-title: PLoS One
– volume: 36
  start-page: 413
  year: 2001
  article-title: Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain
  publication-title: Alcohol Alcohol
– volume: 13
  start-page: 491
  year: 2005
  article-title: Treatment of late-life depression complicated by alcohol dependence
  publication-title: Am J Geriatr Psychiatry
– volume: 32
  start-page: 1652
  year: 2008
  article-title: Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial
  publication-title: Alcohol Clin Exp Res
– issue: 9
  year: 2010
  article-title: Acamprosate for alcohol dependence
  publication-title: Cochrane Database Syst Rev
– volume: 331
  start-page: 1064
  year: 2005
  article-title: Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources
  publication-title: BMJ
– volume: 17
  start-page: 88
  year: 2017
  article-title: Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework
  publication-title: BMC Health Serv Res
– volume: 126
  start-page: 951
  year: 2016
  article-title: Epley and Semont maneuvers for posterior canal benign paroxysmal positional vertigo: A network meta-analysis
  publication-title: Laryngoscope
– volume: 54
  start-page: 700
  year: 1997
  article-title: Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial
  publication-title: Arch Gen Psychiatry
– volume: 16
  start-page: 247
  year: 2007
  article-title: Oxcarbazepine at high dosages for the treatment of alcohol dependence
  publication-title: Am J Addict
– volume: 10
  year: 2018
  article-title: Adding Psychotherapy to the Naltrexone Treatment of Alcohol Use Disorder: Meta-analytic Review
  publication-title: Cureus
– volume: 8
  start-page: 49
  year: 2013
  article-title: Guideline adaptation and implementation planning: a prospective observational study
  publication-title: Implement Sci
– volume: 336
  start-page: 536
  year: 2008
  article-title: Is the declaration of Alma Ata still relevant to primary health care?
  publication-title: BMJ
– volume: 113
  start-page: 220
  year: 2018
  article-title: Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate
  publication-title: Addiction
– volume: 65
  start-page: 1406
  year: 2004
  article-title: Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study
  publication-title: J Clin Psychiatry
– volume: 101
  start-page: 824
  year: 2006
  article-title: Estimating the effect of help-seeking on achieving recovery from alcohol dependence
  publication-title: Addiction
– volume: 9
  start-page: 18
  year: 2010
  article-title: Home visits in the outpatient treatment of individuals dependent on alcohol: Randomized clinical trial
  publication-title: Addict Disord Their Treat
– volume: 384
  start-page: 1953
  year: 2014
  article-title: Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
  publication-title: Lancet
– volume: 45
  start-page: 136
  year: 2010
  article-title: Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes
  publication-title: Alcohol Alcohol
– volume: 28
  start-page: 51
  year: 2004
  article-title: The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis
  publication-title: Alcohol Clin Exp Res
– volume: 57
  start-page: 312
  year: 2008
  article-title: An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients
  publication-title: Pharmacol Res
– ident: 2020112509201012000_371.nov25_2.m3934.14
  doi: 10.1111/j.1530-0277.2007.00536.x
– ident: 2020112509201012000_371.nov25_2.m3934.53
  doi: 10.1186/1748-5908-8-49
– ident: 2020112509201012000_371.nov25_2.m3934.33
  doi: 10.1016/S0306-4603(99)00065-9
– ident: 2020112509201012000_371.nov25_2.m3934.9
  doi: 10.1046/j.1360-0443.2002.00019.x
– ident: 2020112509201012000_371.nov25_2.m3934.49
  doi: 10.1002/14651858.CD001867.pub2
– ident: 2020112509201012000_371.nov25_2.m3934.54
– ident: 2020112509201012000_371.nov25_2.m3934.6
– ident: 2020112509201012000_371.nov25_2.m3934.35
  doi: 10.1097/00019442-200506000-00008
– ident: 2020112509201012000_371.nov25_2.m3934.10
  doi: 10.1186/s13643-017-0462-2
– ident: 2020112509201012000_371.nov25_2.m3934.21
  doi: 10.1371/journal.pone.0099682
– ident: 2020112509201012000_371.nov25_2.m3934.55
  doi: 10.1093/alcalc/agq077
– ident: 2020112509201012000_371.nov25_2.m3934.25
– ident: 2020112509201012000_371.nov25_2.m3934.32
  doi: 10.1001/archpsyc.1997.01830200024004
– ident: 2020112509201012000_371.nov25_2.m3934.11
  doi: 10.7326/M14-2385
– ident: 2020112509201012000_371.nov25_2.m3934.51
  doi: 10.1371/journal.pone.0087366
– ident: 2020112509201012000_371.nov25_2.m3934.1
– ident: 2020112509201012000_371.nov25_2.m3934.40
  doi: 10.15288/jsa.1998.59.631
– ident: 2020112509201012000_371.nov25_2.m3934.56
  doi: 10.1016/j.clinthera.2005.06.015
– ident: 2020112509201012000_371.nov25_2.m3934.26
  doi: 10.1002/jrsm.1044
– ident: 2020112509201012000_371.nov25_2.m3934.27
  doi: 10.1002/sim.3767
– ident: 2020112509201012000_371.nov25_2.m3934.38
  doi: 10.1034/j.1600-0447.2002.02332.x
– ident: 2020112509201012000_371.nov25_2.m3934.58
  doi: 10.1177/0269881112444324
– ident: 2020112509201012000_371.nov25_2.m3934.24
  doi: 10.1016/j.phrs.2008.03.001
– ident: 2020112509201012000_371.nov25_2.m3934.28
  doi: 10.1002/lary.25688
– ident: 2020112509201012000_371.nov25_2.m3934.15
  doi: 10.1136/bmj.38636.593461.68
– ident: 2020112509201012000_371.nov25_2.m3934.22
  doi: 10.1371/journal.pone.0076654
– ident: 2020112509201012000_371.nov25_2.m3934.46
  doi: 10.1111/add.13974
– ident: 2020112509201012000_371.nov25_2.m3934.37
  doi: 10.1001/jamapsychiatry.2013.4642
– ident: 2020112509201012000_371.nov25_2.m3934.52
  doi: 10.1186/s12913-017-2031-8
– ident: 2020112509201012000_371.nov25_2.m3934.17
  doi: 10.1097/01.ALC.0000108656.81563.05
– volume: 33
  start-page: 13
  year: 2005
  ident: 2020112509201012000_371.nov25_2.m3934.36
  article-title: Eficacia de la naltrexona en el tratamiento de mujeres con trastorno por dependencia del alcohol
  publication-title: Actas Esp Psiquiatr
– ident: 2020112509201012000_371.nov25_2.m3934.34
  doi: 10.1111/j.1530-0277.2008.00742.x
– ident: 2020112509201012000_371.nov25_2.m3934.4
– ident: 2020112509201012000_371.nov25_2.m3934.41
  doi: 10.14748/bmr.v30.6393
– ident: 2020112509201012000_371.nov25_2.m3934.18
  doi: 10.1136/bmj.l4898
– ident: 2020112509201012000_371.nov25_2.m3934.39
  doi: 10.1111/j.1600-0447.2001.00150.x
– ident: 2020112509201012000_371.nov25_2.m3934.8
  doi: 10.1136/bmj.39469.432118.AD
– ident: 2020112509201012000_371.nov25_2.m3934.23
  doi: 10.1001/jama.1986.03380110055026
– ident: 2020112509201012000_371.nov25_2.m3934.44
  doi: 10.1093/alcalc/agh136
– ident: 2020112509201012000_371.nov25_2.m3934.59
  doi: 10.1016/j.jsat.2014.11.009
– ident: 2020112509201012000_371.nov25_2.m3934.30
  doi: 10.1080/10550490701375558
– ident: 2020112509201012000_371.nov25_2.m3934.29
  doi: 10.1609/icwsm.v3i1.13937
– ident: 2020112509201012000_371.nov25_2.m3934.50
  doi: 10.1002/14651858.CD004332.pub2
– ident: 2020112509201012000_371.nov25_2.m3934.48
  doi: 10.1111/add.12875
– ident: 2020112509201012000_371.nov25_2.m3934.3
– ident: 2020112509201012000_371.nov25_2.m3934.43
  doi: 10.1097/ADT.0b013e318196d4e5
– ident: 2020112509201012000_371.nov25_2.m3934.16
  doi: 10.1007/978-1-4612-2878-3_44
– ident: 2020112509201012000_371.nov25_2.m3934.12
  doi: 10.1136/bmj.331.7516.541
– ident: 2020112509201012000_371.nov25_2.m3934.57
  doi: 10.1097/01.ALC.0000108656.81563.05
– ident: 2020112509201012000_371.nov25_2.m3934.42
  doi: 10.1093/alcalc/agz106
– ident: 2020112509201012000_371.nov25_2.m3934.13
  doi: 10.1093/alcalc/agq005
– ident: 2020112509201012000_371.nov25_2.m3934.7
– ident: 2020112509201012000_371.nov25_2.m3934.19
  doi: 10.1371/journal.pmed.1003082
– ident: 2020112509201012000_371.nov25_2.m3934.31
  doi: 10.1093/alcalc/36.5.413
– ident: 2020112509201012000_371.nov25_2.m3934.2
  doi: 10.1016/S0140-6736(14)61838-9
– ident: 2020112509201012000_371.nov25_2.m3934.47
  doi: 10.7759/cureus.3107
– ident: 2020112509201012000_371.nov25_2.m3934.5
  doi: 10.1111/j.1360-0443.2006.01433.x
– ident: 2020112509201012000_371.nov25_2.m3934.45
  doi: 10.4088/JCP.v65n1017
– ident: 2020112509201012000_371.nov25_2.m3934.20
  doi: 10.1002/cl2.1080
– reference: 33402357 - BMJ. 2021 Jan 5;372:n5. doi: 10.1136/bmj.n5.
– reference: 33939485 - Ann Intern Med. 2021 May;174(5):JC51. doi: 10.7326/ACPJ202105180-051.
– reference: 33481761 - BMJ. 2020 Nov 25;371:m4129. doi: 10.1136/bmj.m4129.
SSID ssj0002378965
Score 2.544613
SecondaryResourceType review_article
Snippet AbstractObjectiveTo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary...
To determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care. Systematic review and...
ObjectiveTo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.DesignSystematic...
To determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.OBJECTIVETo determine the...
SourceID pubmedcentral
proquest
pubmed
crossref
bmj
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage m3934
SubjectTerms Abstinence
Adult
Alcohol
Alcohol Abstinence - psychology
Alcoholism - psychology
Alcoholism - therapy
Behavior Therapy - methods
Bias
Clinical medicine
Clinical trials
Drug withdrawal
Drugs
Female
Humans
Intervention
Liver diseases
Male
Meta-analysis
Middle Aged
Naltrexone
Patients
Primary care
Primary Health Care - methods
Randomized Controlled Trials as Topic
Systematic review
Treatment Outcome
Title Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis
URI https://bmj.com/content/371/bmj.m3934.full
https://www.ncbi.nlm.nih.gov/pubmed/33239318
https://www.proquest.com/docview/2464302625
https://www.proquest.com/docview/2464608049
https://pubmed.ncbi.nlm.nih.gov/PMC7687021
Volume 371
WOSCitedRecordID wos000595061600017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1756-1833
  dateEnd: 20250930
  omitProxy: false
  ssIdentifier: ssj0002378965
  issn: 1756-1833
  databaseCode: M7P
  dateStart: 19940108
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection (ProQuest)
  customDbUrl:
  eissn: 1756-1833
  dateEnd: 20250930
  omitProxy: false
  ssIdentifier: ssj0002378965
  issn: 1756-1833
  databaseCode: 7X7
  dateStart: 19940108
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1756-1833
  dateEnd: 20250930
  omitProxy: false
  ssIdentifier: ssj0002378965
  issn: 1756-1833
  databaseCode: 7RV
  dateStart: 19940108
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1756-1833
  dateEnd: 20250930
  omitProxy: false
  ssIdentifier: ssj0002378965
  issn: 1756-1833
  databaseCode: BENPR
  dateStart: 19940108
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 1756-1833
  dateEnd: 20250930
  omitProxy: false
  ssIdentifier: ssj0002378965
  issn: 1756-1833
  databaseCode: M2O
  dateStart: 19940108
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database (ProQuest)
  customDbUrl:
  eissn: 1756-1833
  dateEnd: 20250930
  omitProxy: false
  ssIdentifier: ssj0002378965
  issn: 1756-1833
  databaseCode: M2P
  dateStart: 19940108
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9MwFH-iG0K78M0IbJVBHLiY1R-JHS4I0CYOrETTmHqrHMcWRTQda4b48_FL3HSFaRcOsSL7JXH0bL8PP_8ewCsRhJjIraOOKYbeKkG1l5YGbddqJhWX7Tnus89qPNaTSV5Eh9syhlWu1sR2oa4WFn3kB1wG2RkMBp6-O_9JMWsU7q7GFBoD2A6aDcOQrmNe9D4WLpTOszQCCjGRHZTz72_mIsc0yYNwvymM_tEw_w6UvCJ5ju79b5_vw92oc5L33SB5ALdc_RDuHMdd9Ufw-3QVbU5mV0Igl6RZkLkJVeEipgyLQY3rAMEjKcR0uXXDE-S8Q6wgGEX2lqyxoUl3LoaYuiJ1F25O5q4x1EQklMfw9ejw9OMnGjMy0FJmvKGe8VKlqiotHyEwHteZZTbzygY56J021mdGWS90ar31I-lZ5riVSmqjnPHiCWzVi9o9BVIZFRT70ag0zEnOqpKXOigbzkoXLCzHExgGBk3jjFpOW2NFZFOsbDmYwD7ex1-8rv31irdTG_HOMe3Gj-tIX_akN7xvb8Xkda_WHE7gRd8cZihuu5jaLS47miwo5jJPYLcbT_1XhEAIOqYTUBsjrSdA9O_Nlnr2rUUBD3aiCgras5u79Rx2OHoIGKM83YOt5uLS7cNt-6uZLS-GMFAnZ1hOVFvqIWx_OBwXJ0OcSF_assBSFX8A15gpCA
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61BdFeeD8CbTEIpF5C14_EDhJCCKhadbvqYUG9Bcex1UVstu2mLfwpfiPjvLYLVW89cIhk2U5iJ5_HM_b4G4BXHCcxnhgbWiqpX63ioXLChKjtGkWFZKI6x_21LwcDdXCQ7C_A7_YsjHerbGViJajzifFr5JtM4NyJBgOL3h8dhz5qlN9dbUNo1LDYtb_O0WSbvtv5hP_3NWNbn4cft8MmqkCYiZiVoaMsk5HMM8N6ntyNqdhQEztpUJY7q7RxsZbGcRUZZ1xPOBpbZoQUSkurHcfnLsIN4ZnFvKsg2-_WdBiXKomjhsCI8ngzG39_M-aJD8u8iOn5ye8fjfZvx8wLM93Wnf_tG92F241OTT7Ug-AeLNjiPtzaa7wGHsDPYetNT0YXXDynpJyQscYsvIjOUNgVXs4Rf-SG6Dp2MN5BjmpGDuK95N6SGfc1qc_9EF3kpKjd6cnYljrUDdPLQ_hyLf1-BEvFpLBPgORaouHS62WaWsFonrFMoTJljbBoQVoWwDoCIm0kxjStjDEepz6zQkwAaz7ddPGy8o0WS6lp-Nx9WJEfl1V92VW94nmrLahmrZohKoAXXTFKIL-tpAs7Oa3rxGh4iCSAxzV-u7dw7in2qApAziG7q-DZzedLitFhxXKOdrBEBfTp1c16Dsvbw71-2t8Z7D6DFeZXQygNWbQKS-XJqV2Dm-asHE1P1quhSuDbdeP-D83egbw
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61W1Rx4f0ItMUgkLiEXT8SO0gIAe2KqmW1QgX1FhzHFovYbOmmPP4av45xXtuFqrceOESybCexk8_jGXv8DcBjjpMYT4wNLZXUr1bxUDlhQtR2jaJCMlGd4_64L0cjdXiYjFfgd3sWxrtVtjKxEtT5zPg18j4TOHeiwcCivmvcIsbbw5dH30IfQcrvtLbhNGqI7NlfP9B8m7_Y3cZ__YSx4c7Bm7dhE2EgzETMytBRlslI5plhA0_0xlRsqImdNCjXnVXauFhL47iKjDNuIByNLTNCCqWl1Y7jc1dhTaKSIXqw9npnNH7frfAwLlUSRw2dEeVxP5t-eTbliQ_SvIrp5anwH_32bzfNU_Pe8Or__MWuwZVG2yav6uFxHVZscQPW3zX-BDfh50HrZ08mp5w_56SckanGLLyIzlAMFl4CEn8Yh-g6qjDeQY5qrg7i_eeekwUrNqlPBBFd5KSoHe3J1JY61A0HzC34cCH9vg29YlbYu0ByLdGkGQwyTa1gNM9YplDNskZYtC0tC2ALwZE2smSeVmYaj1OfWaEngE2fbrp4VvnTFlepaZjefcCRr2dVfdRVPed5Gy3AFq1aoCuAh10xyia_4aQLOzup68RokogkgDs1lru3cO7J96gKQC6hvKvgec-XS4rJ54r_HC1kiarpvfOb9QDWEe7p_u5o7z5cZn6ZhNKQRRvQK49P7CZcMt_Lyfx4qxm3BD5dNPD_AHg4i9Y
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+interventions+to+maintain+abstinence+from+alcohol+in+primary+care%3A+systematic+review+and+network+meta-analysis&rft.jtitle=BMJ+%28Online%29&rft.au=Cheng%2C+Hung-Yuan&rft.au=McGuinness%2C+Luke+A&rft.au=Elbers%2C+Roy+G&rft.au=MacArthur%2C+Georgina+J&rft.date=2020-11-25&rft.eissn=1756-1833&rft.volume=371&rft_id=info:doi/10.1136%2Fbmj.m3934&rft_id=info%3Apmid%2F33239318&rft.externalDBID=BMJ-UK&rft.externalDocID=bmj
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-1833&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-1833&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-1833&client=summon